Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica L Potter

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
BMJ (Clinical Research Ed.)|July 16, 2015
Providing accessible healthcare to migrants is morally right and cost effectiveJessica L Potter
Critical Social Policy|March 21, 2024
Distanciation as a technology of control in the UK hostile environmentJessica L Potter, Isabel Meier
The Lancet. Oncology|April 4, 2018
The NHS and migrant patients with cancerSophie Williams, Erin Dexter, Jessica L Potter
BMJ (Clinical Research Ed.)|October 10, 2025
Priorities in addressing rifampicin resistant TBTom A Yates, Jessica L Potter, Rouxjeane Venter
BMJ (Clinical Research Ed.)|March 31, 2025
Tuberculosis in the UKJessica L Potter, Felicity Perrin, Emily Shaw, et al.
BMJ Open|September 5, 2019
Improving cardiovascular disease risk communication in NHS Health Checks: a qualitative studyMeredith K D Hawking, Adam Timmis, Fae Wilkins, et al.
Bulletin of the World Health Organization|September 2, 2024
Drug-resistant tuberculosis treatments, the case for a phase III platform trialTom A Yates, Samara Barnes, Martin Dedicoat, et al.
The Lancet. Microbe|July 29, 2024
Bedaquiline: what might the future hold?Emily S Shaw, Neil G Stoker, Jessica L Potter, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
BMJ (Clinical Research Ed.)|July 16, 2015
Providing accessible healthcare to migrants is morally right and cost effectiveJessica L Potter
Critical Social Policy|March 21, 2024
Distanciation as a technology of control in the UK hostile environmentJessica L Potter, Isabel Meier
The Lancet. Oncology|April 4, 2018
The NHS and migrant patients with cancerSophie Williams, Erin Dexter, Jessica L Potter
BMJ (Clinical Research Ed.)|October 10, 2025
Priorities in addressing rifampicin resistant TBTom A Yates, Jessica L Potter, Rouxjeane Venter
BMJ (Clinical Research Ed.)|March 31, 2025
Tuberculosis in the UKJessica L Potter, Felicity Perrin, Emily Shaw, et al.
BMJ Open|September 5, 2019
Improving cardiovascular disease risk communication in NHS Health Checks: a qualitative studyMeredith K D Hawking, Adam Timmis, Fae Wilkins, et al.
Bulletin of the World Health Organization|September 2, 2024
Drug-resistant tuberculosis treatments, the case for a phase III platform trialTom A Yates, Samara Barnes, Martin Dedicoat, et al.
The Lancet. Microbe|July 29, 2024
Bedaquiline: what might the future hold?Emily S Shaw, Neil G Stoker, Jessica L Potter, et al.
Pageof 1